South & Central America Branded Generics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South & Central America Branded Generics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South & Central America Branded Generics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South & Central America Branded Generics Market Regional Analysis

6.2 South & Central America Branded Generics Market Revenue 2020-2028 (US$ Billion)

6.3 South & Central America Branded Generics Market Forecast Analysis

7. South & Central America Branded Generics Market Analysis – by Therapeutic Application

7.1 Oncology

7.1.1 Overview
7.1.2 Oncology: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.2 Cardiovascular Diseases

7.2.1 Overview
7.2.2 Cardiovascular Diseases: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.3 Diabetes

7.3.1 Overview
7.3.2 Diabetes: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.4 Neurology

7.4.1 Overview
7.4.2 Neurology: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.5 Gastrointestinal Diseases

7.5.1 Overview
7.5.2 Gastrointestinal Diseases: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.6 Dermatology Diseases

7.6.1 Overview
7.6.2 Dermatology Diseases: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

7.7 Analgesics and Anti-Inflammatory

7.7.1 Overview
7.7.2 Analgesics and Anti-Inflammatory: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

8. South & Central America Branded Generics Market Analysis – by Distribution Channel

8.1 Hospitals

8.1.1 Overview
8.1.2 Hospitals: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

8.2 Retail Pharmacies

8.2.1 Overview
8.2.2 Retail Pharmacies: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

8.3 Online Pharmacies

8.3.1 Overview
8.3.2 Online Pharmacies: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

8.4 Drug Stores

8.4.1 Overview
8.4.2 Drug Stores: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9. South & Central America Branded Generics Market Analysis – by Drug Class

9.1 Alkylating Agents

9.1.1 Overview
9.1.2 Alkylating Agents: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.2 Antimetabolites

9.2.1 Overview
9.2.2 Antimetabolites: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.3 Hormones

9.3.1 Overview
9.3.2 Hormones: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.4 Antihypertensive

9.4.1 Overview
9.4.2 Antihypertensive: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.5 Lipid-Lowering Drugs

9.5.1 Overview
9.5.2 Lipid-Lowering Drugs: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.6 Antidepressants

9.6.1 Overview
9.6.2 Antidepressants: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.7 Antipsychotics

9.7.1 Overview
9.7.2 Antipsychotics: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

9.8 Antiepileptic

9.8.1 Overview
9.8.2 Antiepileptic: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

10. South & Central America Branded Generics Market Analysis – by Formulation Type

10.1 Oral

10.1.1 Overview
10.1.2 Oral: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

10.2 Parenteral

10.2.1 Overview
10.2.2 Parenteral: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

10.3 Topical

10.3.1 Overview
10.3.2 Topical: South & Central America Branded Generics Market – Revenue and Forecast, 2020-2028 (US$ Billion)

11. South & Central America Branded Generics Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America

11.2.1 South & Central America Branded Generics Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 South & Central America Branded Generics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Brazil: South & Central America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.1.1.1 Brazil: South & Central America Branded Generics Market Breakdown, by Therapeutic Application
11.2.1.1.2 Brazil: South & Central America Branded Generics Market Breakdown, by Distribution Channel
11.2.1.1.3 Brazil: South & Central America Branded Generics Market Breakdown, by Drug Class
11.2.1.1.4 Brazil: South & Central America Branded Generics Market Breakdown, by Formulation Type

11.2.1.2 Argentina: South & Central America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.1.2.1 Argentina: South & Central America Branded Generics Market Breakdown, by Therapeutic Application
11.2.1.2.2 Argentina: South & Central America Branded Generics Market Breakdown, by Distribution Channel
11.2.1.2.3 Argentina: South & Central America Branded Generics Market Breakdown, by Drug Class
11.2.1.2.4 Argentina: South & Central America Branded Generics Market Breakdown, by Formulation Type

11.2.1.3 Rest of South and Central America : South & Central America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.1.3.1 Rest of South and Central America : South & Central America Branded Generics Market Breakdown, by Therapeutic Application
11.2.1.3.2 Rest of South and Central America : South & Central America Branded Generics Market Breakdown, by Distribution Channel
11.2.1.3.3 Rest of South and Central America : South & Central America Branded Generics Market Breakdown, by Drug Class
11.2.1.3.4 Rest of South and Central America : South & Central America Branded Generics Market Breakdown, by Formulation Type

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Aspen Holdings

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 AstraZeneca

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Bausch Health (Valeant Pharmaceuticals)

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Dr. Reddy's Laboratories Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlaxoSmithKline plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Hetero

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Lupin

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Mylan N.V.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Par Pharmaceuticals

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Sandoz International Gmbh

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Sanofi

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Teva Pharmaceutical Industries Ltd.

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

South & Central America Branded Generics Market